Search
Bofutrelvir
go.drugbank.com/drugs/DB21501ExperimentalBofutrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Bofutrelvir is a antiviral 3CL protease inhibitor. … Bofutrelvir has a monoisotopic molecular weight of 452.24 Da.
Ulecaciclib
go.drugbank.com/drugs/DB21595ExperimentalUlecaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Ulecaciclib is a cyclin dependant kinase inhibitor. … Ulecaciclib has a monoisotopic molecular weight of 496.25 Da.
Eciruciclib
go.drugbank.com/drugs/DB21597ExperimentalEciruciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Eciruciclib is a cyclin dependant kinase inhibitor. … Eciruciclib has a monoisotopic molecular weight of 488.28 Da.
Zevotrelvir
go.drugbank.com/drugs/DB21638ExperimentalZevotrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Zevotrelvir is a antiviral 3CL protease inhibitor. … Zevotrelvir has a monoisotopic molecular weight of 537.2 Da.
Orenasitecan
go.drugbank.com/drugs/DB21718ExperimentalOrenasitecan is a small molecule drug. The usage of the INN stem '-tecan' in the name indicates that Orenasitecan is a antineoplastic, topoisomerase I inhibitor. … Orenasitecan has a monoisotopic molecular weight of 1470.58 Da.
Mocaciclib
go.drugbank.com/drugs/DB21730ExperimentalMocaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Mocaciclib is a cyclin dependant kinase inhibitor. … Mocaciclib has a monoisotopic molecular weight of 609.3 Da.
Marimastat
go.drugbank.com/drugs/DB00786InvestigationalUsed in the treatment of cancer, Marmiastat is an angiogenesis and metastasis inhibitor. As an angiogenesis inhibitor it limits the growth and production of blood vessels. … As an antimetatstatic agent it prevents malignant cells from breaching the basement membranes.
Acellular nerve allograft
go.drugbank.com/drugs/DB30293ApprovedInvestigationalApproved by the FDA under a Biologics License Application (BLA) as an acellular nerve scaffold for the treatment of adult and pediatric patients (aged ≥1 month) with sensory, mixed, and motor peripheral … Our team is working on the full update, which will be available soon. [L54673,L54668]
Pramiracetam
go.drugbank.com/drugs/DB13247ApprovedIt was also previously approved in the United States with orphan drug designation [L1469]. … Pramiracetam has been studied for the use in Alzheimer's disease and as an adjunct treatment to restore cognitive functioning post-electroconvulsive therapy in severe depression [L5470].